A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules

Abstract

Protein-Protein Interactions (PPIs) are the key components in many cellular processes including signaling pathways, enzymatic reactions and epigenetic regulation. Abnormal interactions of some proteins may be pathogenic and cause various disorders including cancer and neurodegenerative diseases. Although inhibiting PPIs with small molecules is a challenging task, it gained an increasing interest because of its strong potential for drug discovery and design. The knowledge of the interface as well as the structural and chemical characteristics of the PPIs and their roles in the cellular pathways is necessary for a rational design of small molecules to modulate PPIs. In this study, we review the recent progress in the field and detail the physicochemical properties of PPIs including binding hot spots with a focus on structural methods. Then, we review recent approaches for structural prediction of PPIs. Finally, we revisit the concept of targeting PPIs from a systems biology perspective and we refer to approaches that are usually employed when the structural information is not present.

Research and prospect of peptides for use in obesity treatment (Review)

“…Fragmentation of protein molecules. Fragments of protein molecules were originally hypothesized to be non-functional peptide segments; however, recent studies have revealed that they have important functions (109,110). These can be secreted as hormone molecules into the extracellular space, transported to target organs and serve similar or opposite roles with protein precursors (109).…”

Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators

“…In this area, some covalent PPI inhibitors seem to have also a promising future [14,15]. HTS, virtual screening, fragment-based approaches and the search for peptidomimetics are among the most explored strategies in route towards PPI modulators [14,[16][17][18].…”